Adverse Drug Reaction

Bausch & Lomb responds to U.S. CDC release of data on Fusarium keratitis cases

Published in Drug Week, June 9th, 2006

Bausch & Lomb made the following statement in response to preliminary data released by the U.S. Centers for Disease Control and Prevention as part of its investigation of Fusarium keratitis cases.

These preliminary data require further examination and should be placed in proper context. Bausch & Lomb continues to fully cooperate with the U.S. Food and Drug Administration and the CDC in a comprehensive investigation to determine the root cause of the unusual incidence of fungal keratitis. Bausch & Lomb will review this information later with the CDC in a previously scheduled meeting.

Studies suggest that Fusarium keratitis occurs among...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2006-06-09)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry